CYTOSORBENTS CORPORATION Amortization of Intangible Assets
CYTOSORBENTS CORPORATION (CTSO) reported Amortization of Intangible Assets of $60.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- CYTOSORBENTS CORPORATION amortization of intangible assets for the quarter ending 2026-06-30 was $60.00K, a 0.00% change year-over-year.
- CYTOSORBENTS CORPORATION amortization of intangible assets for the quarter ending 2026-03-31 was $61.00K, a 3.17% decline year-over-year.
- CYTOSORBENTS CORPORATION amortization of intangible assets for the quarter ending 2025-06-30 was $60.00K.
- CYTOSORBENTS CORPORATION amortization of intangible assets for the quarter ending 2025-03-31 was $63.00K.
- CYTOSORBENTS CORPORATION amortization of intangible assets for fiscal 2025 was $262.00K, a 11.49% increase from fiscal 2024.
- CYTOSORBENTS CORPORATION amortization of intangible assets for fiscal 2024 was $235.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 173 month | Amortization of Intangible Assets 176 month | Amortization of Intangible Assets 179 month | Amortization of Intangible Assets 182 month | Amortization of Intangible Assets 185 month | Amortization of Intangible Assets 188 month | Amortization of Intangible Assets 191 month | Amortization of Intangible Assets 194 month | Amortization of Intangible Assets 197 month | Amortization of Intangible Assets 200 month | Amortization of Intangible Assets 206 month | Amortization of Intangible Assets 209 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $60.00K 10-Q · filed 2026-08-06 | $123.00K 10-Q · filed 2026-08-06 | ||||||||||||||
| 2026-03-31 | $61.00K 10-Q · filed 2026-05-13 | |||||||||||||||
| 2025-12-31 | $262.00K 10-K · filed 2026-03-30 | |||||||||||||||
| 2025-06-30 | $60.00K 10-Q · filed 2026-08-06 | $124.00K 10-Q · filed 2026-08-06 | ||||||||||||||
| 2025-03-31 | $63.00K 10-Q · filed 2026-05-13 | |||||||||||||||
| 2024-12-31 | $235.00K 10-K · filed 2026-03-30 | |||||||||||||||
| 2014-06-30 | $183.56K 10-Q · filed 2014-08-12 | |||||||||||||||
| 2014-03-31 | $183.56K 10-Q · filed 2014-05-14 | |||||||||||||||
| 2013-09-30 | $183.56K 10-Q · filed 2013-11-06 | |||||||||||||||
| 2013-06-30 | $183.56K 10-Q · filed 2013-08-14 | |||||||||||||||
| 2013-03-31 | $183.56K 10-Q · filed 2013-05-15 | |||||||||||||||
| 2012-12-31 | $183.56K 10-K · filed 2013-04-03 | |||||||||||||||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-21 | $183.56K 10-Q · filed 2012-11-21 | ||||||||||||||
| 2012-06-30 | $183.56K 10-Q · filed 2012-08-13 | |||||||||||||||
| 2012-03-31 | $183.56K 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | $183.56K 10-K · filed 2012-03-30 | |||||||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-21 | $183.56K 10-Q · filed 2011-11-14 | ||||||||||||||
| 2011-06-30 | $183.56K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |